Vivos Therapeutics (VVOS) Revenue & Revenue Breakdown
Vivos Therapeutics Revenue Highlights
Latest Revenue (Y)
$13.80M
Latest Revenue (Q)
$4.05M
Main Segment (Y)
Center Revenue
Vivos Therapeutics Revenue by Period
Vivos Therapeutics Revenue by Year
| Date | Revenue | Change |
|---|---|---|
| 2023-12-31 | $13.80M | -13.87% |
| 2022-12-31 | $16.02M | -5.10% |
| 2021-12-31 | $16.89M | 29.23% |
| 2020-12-31 | $13.07M | 14.68% |
| 2019-12-31 | $11.39M | 200.43% |
| 2018-12-31 | $3.79M | - |
Vivos Therapeutics generated $13.80M in revenue during NA 2023, up -13.87% compared to the previous quarter, and up 363.93% compared to the same period a year ago.
Vivos Therapeutics Revenue by Quarter
| Date | Revenue | Change |
|---|---|---|
| 2024-06-30 | $4.05M | 18.57% |
| 2024-03-31 | $3.42M | 5.26% |
| 2023-12-31 | $3.25M | -1.61% |
| 2023-09-30 | $3.30M | -2.77% |
| 2023-06-30 | $3.40M | -11.98% |
| 2023-03-31 | $3.86M | -2.35% |
| 2022-12-31 | $3.95M | -6.97% |
| 2022-09-30 | $4.25M | 1.48% |
| 2022-06-30 | $4.18M | 20.92% |
| 2022-03-31 | $3.46M | -21.26% |
| 2021-12-31 | $4.39M | -3.33% |
| 2021-09-30 | $4.55M | 1.09% |
| 2021-06-30 | $4.50M | 30.42% |
| 2021-03-31 | $3.45M | 4.26% |
| 2020-12-31 | $3.31M | 0.47% |
| 2020-09-30 | $3.29M | 0.62% |
| 2020-06-30 | $3.27M | 2.34% |
| 2020-03-31 | $3.20M | 4.61% |
| 2019-12-31 | $3.06M | -7.84% |
| 2019-09-30 | $3.32M | 32.06% |
| 2019-06-30 | $2.51M | -0.00% |
| 2019-03-31 | $2.51M | - |
Vivos Therapeutics generated $4.05M in revenue during Q2 2024, up 18.57% compared to the previous quarter, and up 105.11% compared to the same period a year ago.
Vivos Therapeutics Revenue Breakdown
Vivos Therapeutics Revenue Breakdown by Product
Annual Revenue by Product
| Product/Service | Dec 23 | Dec 22 | Dec 21 | Dec 20 |
|---|---|---|---|---|
| Center Revenue | $189.00K | $561.00K | $480.00K | $341.96K |
| Management Service Revenue | - | $63.00K | $313.00K | - |
Vivos Therapeutics's latest annual revenue breakdown by segment (product or service), as of Dec 23: Center Revenue (100.00%).
Quarterly Revenue by Product
| Product/Service | Jun 24 | Mar 24 | Dec 23 | Jun 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Service | $2.08M | $1.75M | - | - | - | - | - | - | - | - | - | - |
| Appliances | $1.58M | $1.15M | - | - | - | - | - | - | - | - | - | - |
| VIP | $1.17M | $907.00K | - | - | - | - | - | - | - | - | - | - |
| Sponsorship Seminar Other | $224.00K | $122.00K | - | - | - | - | - | - | - | - | - | - |
| Billing Intelligence Services | $213.00K | $225.00K | - | - | - | - | - | - | - | - | - | - |
| Product | $1.98M | $1.67M | - | - | - | - | - | - | - | - | - | - |
| Center Revenue | - | - | $90.00K | $25.00K | $50.00K | $105.00K | $219.00K | $186.00K | $135.65K | $134.49K | $118.09K | $91.77K |
| Management Service Revenue | - | - | - | $574.00K | $-19.00K | $11.00K | $40.00K | $24.00K | $90.00K | $90.00K | $74.00K | - |
Vivos Therapeutics's latest quarterly revenue breakdown by segment (product or service), as of Jun 24: Service (28.71%), Product (27.28%), Appliances (21.76%), VIP (16.21%), Sponsorship Seminar Other (3.09%), and Billing Intelligence Services (2.94%).
Vivos Therapeutics Revenue Breakdown by Country
Quarterly Revenue by Country
| Country | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 |
|---|---|---|---|---|---|---|---|---|
| Management Service Revenue | $-19.00K | $11.00K | $40.00K | $24.00K | $90.00K | $90.00K | $74.00K | - |
| Center Revenue | $50.00K | $105.00K | $219.00K | $186.00K | $135.65K | $134.49K | $118.09K | $91.77K |
Vivos Therapeutics's latest quarterly revenue breakdown by geography, as of Dec 22: Center Revenue (161.29%), and Management Service Revenue (-61.29%).
Vivos Therapeutics Peer Comparison by Revenue
| Ticker | Company | Last Year Revenue | Last Quarter Revenue |
|---|---|---|---|
| RPID | Rapid Micro Biosystems | $22.52M | $6.62M |
| HSCS | Heart Test Laboratories | $18.60M | - |
| VVOS | Vivos Therapeutics | $13.80M | $4.05M |
| NUWE | Nuwellis | $8.86M | $2.19M |
| NAOV | NanoVibronix | $2.28M | $817.00K |
| TIVC | Tivic Health Systems | $1.18M | $140.00K |
| TLIS | Talis Biomedical | $412.00K | - |
| BJDX | Bluejay Diagnostics | - | - |
| BBLG | Bone Biologics | - | - |
VVOS Revenue FAQ
What is Vivos Therapeutics’s yearly revenue?
Vivos Therapeutics's yearly revenue for 2023 was $13.8M, representing a decrease of -13.87% compared to 2022. The company's yearly revenue for 2022 was $16.02M, representing a decrease of -5.10% compared to 2021. VVOS's yearly revenue for 2021 was $16.88M, representing an increase of 29.23% compared to 2020.
What is Vivos Therapeutics’s quarterly revenue?
Vivos Therapeutics's quarterly revenue for Q2 2024 was $4.05M, a 18.57% increase from the previous quarter (Q1 2024), and a 19.41% increase year-over-year (Q2 2023). The company's quarterly revenue for Q1 2024 was $3.42M, a 5.26% increase from the previous quarter (Q4 2023), and a -11.36% decrease year-over-year (Q1 2023). VVOS's quarterly revenue for Q4 2023 was $3.25M, a -1.61% decrease from the previous quarter (Q3 2023), and a -17.77% decrease year-over-year (Q4 2022).
What is Vivos Therapeutics’s revenue growth rate?
Vivos Therapeutics's revenue growth rate for the last 3 years (2021-2023) was -18.26%, and for the last 5 years (2019-2023) was 21.13%.
What are Vivos Therapeutics’s revenue streams?
Vivos Therapeutics's revenue streams in c 23 are Center Revenue
What is Vivos Therapeutics’s main source of revenue?
For the fiscal year ending Dec 23, the largest source of revenue of Vivos Therapeutics was Center Revenue. This segment made a revenue of $189K, representing 100.00% of the company's total revenue.